Catalyst

Slingshot members are tracking this event:

Biogen (BIIB) and Ionis (IONS) Announce Phase 3 CHERISH Interim Results Evaluating SPINRAZA in Later-Onset Spinal Muscular Atrophy (SMA)

Source Link:
http://media.biogen.com/press-release/corporate/biogen-and-ionis-pharmaceuticals-announce-spinraza-nusinersen-meets-primary-

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BIIB
100%
IONS
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Nov 07, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Cherish, Spinraza, Later-onset, Spinal Muscular Atrophy
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.